These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15339075)

  • 1. Clinical manifestations of cutaneous graft-versus-host disease after allogeneic haematopoietic cell transplantation: long-term follow-up results in a single Turkish centre.
    Sanli H; Ekmekçi P; Arat M; Gürman G
    Acta Derm Venereol; 2004; 84(4):296-301. PubMed ID: 15339075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic cutaneous graft-versus-host disease in children: A report of 14 patients from a tertiary care pediatric dermatology clinic.
    Nanda A; Husain MAA; Al-Herz W; Almekaimi A; Al-Sabah H; Al-Otaibi M
    Pediatr Dermatol; 2018 May; 35(3):343-353. PubMed ID: 29536565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graft-versus-host disease-associated angiomatosis: a clinicopathologically distinct entity.
    Kaffenberger BH; Zuo RC; Gru A; Plotner AN; Sweeney SA; Devine SM; Hymes SR; Cowen EW
    J Am Acad Dermatol; 2014 Oct; 71(4):745-53. PubMed ID: 24993601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-Dose Antithymocyte Globulin for Graft-versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation.
    Bryant A; Mallick R; Huebsch L; Allan D; Atkins H; Anstee G; Sabloff M; Scrivens N; Maze D; Bredeson C; Kekre N
    Biol Blood Marrow Transplant; 2017 Dec; 23(12):2096-2101. PubMed ID: 28821454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serious graft-versus-host disease after hematopoietic cell transplantation following nonmyeloablative conditioning.
    Flowers ME; Traina F; Storer B; Maris M; Bethge WA; Carpenter P; Appelbaum F; Storb R; Sandmaier BM; Martin PJ
    Bone Marrow Transplant; 2005 Feb; 35(3):277-82. PubMed ID: 15558037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colonoscopy in the diagnosis of intestinal graft versus host disease and cytomegalovirus enteritis following allogeneic haematopoietic stem cell transplantation.
    He JD; Liu YL; Wang ZF; Liu DH; Chen H; Chen YH
    Chin Med J (Engl); 2008 Jul; 121(14):1285-9. PubMed ID: 18713549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors identifiable at the time of onset of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation.
    Lee KH; Choi SJ; Lee JH; Lee JS; Kim WK; Lee KB; Sohn SK; Kim JG; Kim DH; Seol M; Lee YS; Lee JH
    Haematologica; 2005 Jul; 90(7):939-48. PubMed ID: 15996932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation.
    Martin PJ; McDonald GB; Sanders JE; Anasetti C; Appelbaum FR; Deeg HJ; Nash RA; Petersdorf EW; Hansen JA; Storb R
    Biol Blood Marrow Transplant; 2004 May; 10(5):320-7. PubMed ID: 15111931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalidomide after allogeneic haematopoietic stem cell transplantation: activity in chronic but not in acute graft-versus-host disease.
    Kulkarni S; Powles R; Sirohi B; Treleaven J; Saso R; Horton C; Atra A; Ortin M; Rudin C; Goyal S; Sankpal S; Meller S; Pinkerton CR; Mehta J; Singhal S
    Bone Marrow Transplant; 2003 Jul; 32(2):165-70. PubMed ID: 12838281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cutaneous manifestations of graft-versus-host disease].
    Karrer S; Holler E; Szeimies RM
    Med Klin (Munich); 2001 Aug; 96(8):457-66. PubMed ID: 11560046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy.
    Creamer D; Martyn-Simmons CL; Osborne G; Kenyon M; Salisbury JR; Devereux S; Pagliuca A; Ho AY; Mufti GJ; du Vivier AW
    Arch Dermatol; 2007 Sep; 143(9):1157-62. PubMed ID: 17875877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic cutaneous sclerodermoid graft-versus-host disease: evaluation by 20-MHz sonography.
    Gottlöber P; Leiter U; Friedrich W; Bunjes D; Schulz A; Kerscher M; Peter RU
    J Eur Acad Dermatol Venereol; 2003 Jul; 17(4):402-7. PubMed ID: 12834449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pentraxin 3 plasma levels at graft-versus-host disease onset predict disease severity and response to therapy in children given haematopoietic stem cell transplantation.
    Dander E; De Lorenzo P; Bottazzi B; Quarello P; Vinci P; Balduzzi A; Masciocchi F; Bonanomi S; Cappuzzello C; Prunotto G; Pavan F; Pasqualini F; Sironi M; Cuccovillo I; Leone R; Salvatori G; Parma M; Terruzzi E; Pagni F; Locatelli F; Mantovani A; Fagioli F; Biondi A; Garlanda C; Valsecchi MG; Rovelli A; D'Amico G
    Oncotarget; 2016 Dec; 7(50):82123-82138. PubMed ID: 27893415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor compatibility and performance status affect outcome of allogeneic haematopoietic stem cell transplant in patients with relapsed or refractory acute myeloid leukaemia.
    Damiani D; Tiribelli M; Geromin A; Cerno M; Sperotto A; Toffoletti E; Simeone E; Michelutti A; Cavallin M; Fanin R
    Ann Hematol; 2012 Dec; 91(12):1937-43. PubMed ID: 22893485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
    Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cecum ulcer is a reliable endoscopic finding in cytomegalovirus colitis concomitant with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Matsuda K; Ono S; Ishikawa M; Miyamoto S; Abiko S; Tsuda M; Yamamoto K; Kudo T; Shimizu Y; Hayase E; Hashimoto D; Teshima T; Matsuno Y; Sakamoto N
    Ann Hematol; 2018 May; 97(5):877-883. PubMed ID: 29340759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic hematopoietic stem cell transplantation in Primary Cutaneous T Cell Lymphoma.
    Cudillo L; Cerretti R; Picardi A; Mariotti B; De Angelis G; Cantonetti M; Postorino M; Ceresoli E; De Santis G; Nasso D; Pisani F; Scala E; Di Piazza F; Lanti A;
    Ann Hematol; 2018 Jun; 97(6):1041-1048. PubMed ID: 29442161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease.
    Bridge AT; Nelson RP; Schwartz JE; Mirowski GW; Billings SD
    Am J Dermatopathol; 2007 Feb; 29(1):1-6. PubMed ID: 17284954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dermoscopic Follow-Up of the Skin towards Acute Graft-versus-Host-Disease in Patients after Allogeneic Hematopoietic Stem Cell Transplantation.
    Kaminska-Winciorek G; Czerw T; Kruzel T; Giebel S
    Biomed Res Int; 2016; 2016():4535717. PubMed ID: 27446950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for chronic graft-versus-host disease after allogeneic stem cell transplantation in children.
    Kondo M; Kojima S; Horibe K; Kato K; Matsuyama T
    Bone Marrow Transplant; 2001 Apr; 27(7):727-30. PubMed ID: 11360113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.